Preferred Label : binimetinib;

CISMeF synonym : MEK162;

Is substance : O;

UNII : 181R97MR71;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/mektovi
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
binimetinib
binimetinib
drug approval
europe
treatment outcome
melanoma
antineoplastic combined chemotherapy protocols
encorafenib
BRAF V600 Mutation
melanoma
mutation
proto-oncogene proteins b-raf
administration, oral
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
MAP kinase kinase 1
MAP kinase kinase 2
Progression-Free survival
survival analysis
drug evaluation, preclinical
Binimetinib/Encorafenib Regimen
Tyrosine Kinase Inhibitors
binimetinib
binimetinib
benzimidazoles
binimetinib
disease-free survival
benzimidazoles
carbamates
sulfonamides

---
Nous contacter.
08/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.